World-first human trial finds arthritis drug can suppress progression of type 1 diabetes

Researchers at St Vincent’s Institute of Medical Research (SVI) in Melbourne have shown that a commonly prescribed rheumatoid arthritis drug can suppress the progression of type 1 diabetes.

Leave A Comment

Your email address will not be published. Required fields are marked *